{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:35Z","timestamp":1791499295550,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02323-7","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T01:14:44Z","timestamp":1710292484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The cytotoxic effects of prazosin, chlorpromazine, and haloperidol on hepatocellular carcinoma and immortalized non-tumor liver cells"],"prefix":"10.1007","volume":"41","author":[{"given":"Seth","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungtae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"issue":"6","key":"2323_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.21147\/j.issn.1000-9604.2022.06.02","volume":"34","author":"Q Li","year":"2022","unstructured":"Li Q, Cao M, Lei L, Yang F, Li H, Yan X, He S, Zhang S, Teng Y, Xia C, Chen W. Burden of liver cancer: From epidemiology to prevention. Chin J Cancer Res. 2022;34(6):554\u201366. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2022.06.02.","journal-title":"Chin J Cancer Res"},{"key":"2323_CR2","first-page":"863","volume":"18","author":"N Tunissiolli","year":"2017","unstructured":"Tunissiolli N, Castanhole-Nunes M, Biselli-Chicote P, Pavarino \u00c9, Silva R, Silva R, Goloni-Bertollo E. Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pac J Cancer Prev. 2017;18:863\u201372.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2323_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005904","author":"P Golabi","year":"2017","unstructured":"Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear C, Younossi Z. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore). 2017. https:\/\/doi.org\/10.1097\/MD.0000000000005904.","journal-title":"Medicine (Baltimore)"},{"key":"2323_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter F, Toni E, Wang X. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5:87. https:\/\/doi.org\/10.1038\/s41392-020-0187-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2323_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/or.2021.7983","volume":"45","author":"G Yang","year":"2021","unstructured":"Yang G, Xing J, Aikemu B, Jing S, Minhua Z. Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer. Oncol Rep. 2021;45:32. https:\/\/doi.org\/10.3892\/or.2021.7983.","journal-title":"Oncol Rep"},{"key":"2323_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836333","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang Y, Shi X, Li J, Wang L, Xie C, Wang Y. Chenodeoxycholic acid enhances the effect of sorafenib in inhibiting HepG2 cell growth through EGFR\/Stat3 pathway. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.836333.","journal-title":"Front Oncol"},{"key":"2323_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/JHC.S107370","volume":"4","author":"D Erstad","year":"2017","unstructured":"Erstad D, Tanabe K. Hepatocellular carcinoma: early-stage management challenges. J Hepatocell Carcinoma. 2017;4:81\u201392. https:\/\/doi.org\/10.2147\/JHC.S107370.","journal-title":"J Hepatocell Carcinoma"},{"key":"2323_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"J Yang","year":"2019","unstructured":"Yang J, Hainaut P, Gores G, Amadou A, Plymoth A, Roberts L. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2323_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jhep.2011.05.012","volume":"55","author":"M Silva","year":"2011","unstructured":"Silva M, Sherman M. Criteria for liver transplantation for HCC: what should the limits be? J Hepatol. 2011;55:1137\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2011.05.012.","journal-title":"J Hepatol"},{"key":"2323_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/cco.2018.08.12","volume":"7","author":"A Chawla","year":"2018","unstructured":"Chawla A, Ferrone C. Hepatocellular carcinoma surgical therapy perspectives on the current limits to resection. Chin Clin Oncol. 2018;7:48.","journal-title":"Chin Clin Oncol"},{"key":"2323_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou L, Xie N, Edouard N, Zhang T, Cui Y, Huang C. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther. 2020;5:113. https:\/\/doi.org\/10.1038\/s41392-020-00213-8.","journal-title":"Signal Transduct Target Ther"},{"key":"2323_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1593\/neo.07475","volume":"9","author":"S Lin","year":"2007","unstructured":"Lin S, Chueh S, Hsiao C, Li T, Chen T, Liao C, Lyu P, Guh J. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia. 2007;9:830\u20139. https:\/\/doi.org\/10.1593\/neo.07475.","journal-title":"Neoplasia"},{"key":"2323_CR13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.18632\/oncotarget.28010","volume":"12","author":"P Kamgar-Dayhoff","year":"2021","unstructured":"Kamgar-Dayhoff P, Brelidze T. Multifaceted effect of chlorpromazine in cancer implications for cancer treatment. Oncotarget. 2021;12:1406.","journal-title":"Oncotarget"},{"key":"2323_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/biomedicines8120595","volume":"8","author":"F Papadopoulos","year":"2020","unstructured":"Papadopoulos F, Isihou R, Alexiou G, Tsalios T, Vartholomatos E, Markopoulos G, Sioka C, Tsekeris P, Kyritsis A, Galani V. Haloperidol induced cell cycle arrest and apoptosis in glioblastoma cells. Biomedicines. 2020;8:595. https:\/\/doi.org\/10.3390\/biomedicines8120595.","journal-title":"Biomedicines"},{"key":"2323_CR15","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.21037\/tcr.2019.09.03","volume":"8","author":"M An","year":"2019","unstructured":"An M, Ma W, Jia H, Li Y, Feng J, Meng J, Hui Q, Liu J. Prazosin inhibits the growth and mobility of osteosarcoma cells. Transl Cancer Res. 2019;8:1997.","journal-title":"Transl Cancer Res"},{"key":"2323_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00280-021-04386-z","volume":"89","author":"F Xu","year":"2022","unstructured":"Xu F, Xi H, Liao M, Zhang Y, Ma H, Wu M, Xue Q, Sun H, Zhang Y, Xia Y. Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2\/M cell cycle arrest, apoptosis, and autophagy. Cancer Chemother Pharmacol. 2022;89:331\u201346. https:\/\/doi.org\/10.1007\/s00280-021-04386-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2323_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5.","journal-title":"Cell Res"},{"key":"2323_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.882571","author":"F Pan","year":"2022","unstructured":"Pan F, Lin X, Hao L, Wang T, Song H, Wang R. The critical role of ferroptosis in hepatocellular carcinoma. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.882571.","journal-title":"Front Cell Dev Biol"},{"key":"2323_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cdd.2009.195","volume":"17","author":"I Poon","year":"2010","unstructured":"Poon I, Hulett M, Parish C. Molecular mechanisms of late apoptotic\/necrotic cell clearance. Cell Death Differ. 2010;17:381\u201397. https:\/\/doi.org\/10.1038\/cdd.2009.195.","journal-title":"Cell Death Differ"},{"key":"2323_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12964-019-0437-0","volume":"17","author":"I Shlomovitz","year":"2019","unstructured":"Shlomovitz I, Speir M, Gerlic M. Flipping the dogma \u2013 phosphatidylserine in non-apoptotic cell death. Cell Commun Signal. 2019;17:139. https:\/\/doi.org\/10.1186\/s12964-019-0437-0.","journal-title":"Cell Commun Signal"},{"key":"2323_CR21","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.biopha.2019.01.020","volume":"111","author":"K Morgan","year":"2019","unstructured":"Morgan K, Martucci N, Kozlowska A, et al. Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line. Biomed Pharmacother. 2019;111:1408\u201316. https:\/\/doi.org\/10.1016\/j.biopha.2019.01.020.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2323_CR22","first-page":"31","volume":"35","author":"R Fuchs","year":"2015","unstructured":"Fuchs R, Schwach G, Stracke A, et al. The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT. Anticancer Res. 2015;35(1):31\u20138.","journal-title":"Anticancer Res"},{"issue":"10","key":"2323_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1593\/neo.07475","volume":"9","author":"SC Lin","year":"2007","unstructured":"Lin SC, Chueh SC, Hsiao CJ, et al. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia. 2007;9(10):830\u20139. https:\/\/doi.org\/10.1593\/neo.07475.","journal-title":"Neoplasia"},{"issue":"1","key":"2323_CR24","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1038\/s41467-020-17666-8","volume":"11","author":"S Rai","year":"2020","unstructured":"Rai S, Tanaka H, Suzuki M, et al. Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V. Nat Commun. 2020;11(1):4147. https:\/\/doi.org\/10.1038\/s41467-020-17666-8.","journal-title":"Nat Commun"},{"key":"2323_CR25","unstructured":"Mann, S.K., Marwaha, R., Chlorpromazine. In: StatPearls. StatPearls Publishing; 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553079\/"},{"key":"2323_CR26","unstructured":"Basquez, R., Pippin, M.M. Prazosin. In: StatPearls. StatPearls Publishing; 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555959\/"},{"key":"2323_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00204-013-1169-3","volume":"88","author":"J Fang","year":"2014","unstructured":"Fang J, Han T, Wu Q, Beland F, Chang C, Guo L, Fuscoe J. Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014;88:609\u201323. https:\/\/doi.org\/10.1007\/s00204-013-1169-3.","journal-title":"Arch Toxicol"},{"key":"2323_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108749","author":"Y Li","year":"2019","unstructured":"Li Y, Zuo H, Wang H, Hu A. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS\/MAPKs signaling. Biomed Pharmacother. 2019. https:\/\/doi.org\/10.1016\/j.biopha.2019.108749.","journal-title":"Biomed Pharmacother"},{"key":"2323_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","author":"U Srinivas","year":"2019","unstructured":"Srinivas U, Tan B, Vellayappan B, Jeyasekharan A. ROS and the DNA damage response in cancer. Redox Biol. 2019. https:\/\/doi.org\/10.1016\/j.redox.2018.101084.","journal-title":"Redox Biol"},{"key":"2323_CR30","doi-asserted-by":"publisher","unstructured":"Zhang, Y., Cao, Y., Luo, S., Mukerabigwi, J.F., Liu, M. Chapter 8 - Nanoparticles as drug delivery systems of combination therapy for cancer. In: Grumezescu AM, ed. Nanobiomaterials in Cancer Therapy. William Andrew Publishing, 2016, 253\u2013280. doi:https:\/\/doi.org\/10.1016\/B978-0-323-42863-7.00008-6","DOI":"10.1016\/B978-0-323-42863-7.00008-6"},{"issue":"7","key":"2323_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/09687688.2010.521200","volume":"27","author":"B Yu","year":"2010","unstructured":"Yu B, Tai HC, Xue W, Lee LJ, Lee RJ. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010;27(7):286\u201398. https:\/\/doi.org\/10.3109\/09687688.2010.521200.","journal-title":"Mol Membr Biol"},{"issue":"26","key":"2323_CR32","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","volume":"36","author":"JE Lancet","year":"2018","unstructured":"Lancet JE, Uy GL, Cortes JE, et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol. 2018;36(26):2684\u201392. https:\/\/doi.org\/10.1200\/JCO.2017.77.6112.","journal-title":"J Clin Oncol"},{"issue":"19","key":"2323_CR33","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.3390\/ijms221910774","volume":"22","author":"N Juaid","year":"2021","unstructured":"Juaid N, Amin A, Abdalla A, et al. Anti-hepatocellular carcinoma biomolecules: molecular targets insights. Int J Mol Sci. 2021;22(19):10774. https:\/\/doi.org\/10.3390\/ijms221910774.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2323_CR34","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2174\/1568009623666230503094346","volume":"23","author":"A Singh","year":"2023","unstructured":"Singh A, Mishra S, Sharma S, Ojha S, Yagnik S, Pandey S. Ligand-mediated targeted drug delivery approaches against hepatocellular carcinoma. Curr Cancer Drug Targets. 2023;23(11):879\u201388. https:\/\/doi.org\/10.2174\/1568009623666230503094346.","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02323-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T09:17:55Z","timestamp":1711617475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02323-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2323"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02323-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"87"}}